{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T19:55:09Z","timestamp":1775332509231,"version":"3.50.1"},"reference-count":170,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.clindermatol.2006.07.007","type":"journal-article","created":{"date-parts":[[2006,9,11]],"date-time":"2006-09-11T11:12:21Z","timestamp":1157973141000},"page":"414-429","source":"Crossref","is-referenced-by-count":118,"title":["Cutaneous vasculitis: diagnosis and management"],"prefix":"10.1016","volume":"24","author":[{"given":"J. Andrew","family":"Carlson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Frank","family":"Cavaliere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane M.","family":"Grant-Kels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2006.07.007_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.dad.0000181109.54532.c5","article-title":"Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis","volume":"27","author":"Carlson","year":"2005","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/ard.59.6.478","article-title":"A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature","volume":"59","author":"Sorensen","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/rheumatology\/35.10.958","article-title":"Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis nodosa group","volume":"35","author":"Guillevin","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-129-5-199809010-00001","article-title":"Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis","volume":"129","author":"Rao","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archderm.130.7.899","article-title":"Vasculitis affecting the skin. A review","volume":"130","author":"Jennette","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hci015","article-title":"Primary systemic vasculitis: clinical features and mortality","volume":"98","author":"Lane","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib7","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/rheumatology\/41.10.1138","article-title":"Evaluation of the Sorensen diagnostic criteria in the classification of systemic vasculitis","volume":"41","author":"Lane","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib8","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/art.1780390720","article-title":"Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis","volume":"39","author":"Watts","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archderm.134.3.309","article-title":"Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients","volume":"134","author":"Sais","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2340\/0001555575125129","article-title":"Henoch-Schonlein purpura: clinicopathologic correlation of cutaneous vascular IgA deposits and the relationship to leukocytoclastic vasculitis","volume":"75","author":"Helander","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-4632.2004.01714.x","article-title":"Diagnostic, prognostic and pathogenic value of the direct immunofluorescence test in cutaneous leukocytoclastic vasculitis","volume":"43","author":"Barnadas","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00000372-199906000-00005","article-title":"A clinical and histologic study of 37 cases of immunoglobulin A\u2013associated vasculitis","volume":"21","author":"Magro","year":"1999","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00002281-200101000-00005","article-title":"\u201cEssential\u201d cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin","volume":"13","author":"Stone","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-4632.2005.02898.x","article-title":"Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment","volume":"45","author":"Russell","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/01.dad.0000246646.45651.a2","article-title":"Cutaneous vasculitis update: specific vasculitic syndromes","author":"Carlson","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11926-002-0028-7","article-title":"Pseudovasculitis: mechanisms of vascular injury and clinical spectrum","volume":"4","author":"Grau","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-4362.2003.01914.x","article-title":"Clinical utility of ANCA tests for the dermatologist","volume":"42","author":"Gibson","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00002281-200401000-00004","article-title":"Clinical applications of antineutrophil cytoplasmic antibody testing","volume":"16","author":"Schmitt","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/0003-4819-126-11-199706010-00003","article-title":"Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease","volume":"126","author":"Merkel","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.10997","article-title":"Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction","volume":"49","author":"Vassilopoulos","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib21","first-page":"920","article-title":"Cutaneous vasculitis in a defined population\u2014clinical and epidemiological associations","volume":"25","author":"Watts","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00005792-199909000-00002","article-title":"Systemic vasculitis in adults in northwestern Spain. Clinical and epidemiologic aspects","volume":"78","author":"Gonzalez-Gay","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-196401000-00003","article-title":"Cutaneous and visceral syndromes of necrotizing or \u201callergic\u201d angiitis: a study of 38 cases","volume":"43","author":"Winkelmann","year":"1964","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.berh.2004.09.001","article-title":"Classification and diagnostic criteria in systemic vasculitis","volume":"19","author":"Saleh","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib25","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-4362.1995.tb04398.x","article-title":"Idiopathic hypersensitivity vasculitis: clinicopathologic correlation of 61 cases","volume":"34","author":"Ratnam","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/archderm.138.3.412","article-title":"Cutaneous small vessel vasculitis: an entity with frequent renal involvement","volume":"138","author":"Ioannidou","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/archderm.133.4.438","article-title":"Schonlein-Henoch purpura in adult patients. Predictive factors for IgA glomerulonephritis in a retrospective study of 57 cases","volume":"133","author":"Tancrede-Bohin","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1600-0560.1987.tb00500.x","article-title":"Cutaneous leukocytoclastic vasculitis: correlation of histopathological changes with clinical severity and course","volume":"14","author":"Hodge","year":"1987","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archderm.121.2.220","article-title":"Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases","volume":"121","author":"Sanchez","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib30","first-page":"562","article-title":"The prognostic significance of vascular immunoglobulin deposits in 94 cases of cutaneous leukocytoclastic vasculitis","volume":"27","author":"Lerner","year":"2000","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0091-6749(96)70247-6","article-title":"Leukocytoclastic vasculitis and common variable immunodeficiency: successful treatment with intravenous immune globulin","volume":"98","author":"Sais","year":"1996","journal-title":"J Allergy Clin Immunol"},{"issue":"3 Pt 2","key":"10.1016\/j.clindermatol.2006.07.007_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(92)70069-R","article-title":"Urticarial vasculitis: a histopathologic and clinical review of 72 cases","volume":"26","author":"Mehregan","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"6 Pt 1","key":"10.1016\/j.clindermatol.2006.07.007_bib33","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0190-9622(24)00193-2","article-title":"Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis","volume":"38","author":"Davis","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1034\/j.1600-0625.2001.100602.x","article-title":"Different pathways leading to cutaneous leukocytoclastic vasculitis in mice","volume":"10","author":"Sunderkotter","year":"2001","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3346\/jkms.2005.20.4.677","article-title":"Hypereosinophilia presenting as eosinophilic vasculitis and multiple peripheral artery occlusions without organ involvement","volume":"20","author":"Kim","year":"2005","journal-title":"J Korean Med Sci"},{"issue":"2 Pt 1","key":"10.1016\/j.clindermatol.2006.07.007_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0190-9622(96)90318-7","article-title":"Eosinophilic vasculitis in connective tissue disease","volume":"35","author":"Chen","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.20030850","article-title":"Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis","volume":"199","author":"Ma-Krupa","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib38","first-page":"72","article-title":"Cutaneous lymphocytic vasculitis: a definition, a review, and a proposed classification","volume":"13","author":"Carlson","year":"1996","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib39","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1046\/j.1523-1755.2002.00254.x","article-title":"Acute renal allograft rejection with intimal arteritis: histologic predictors of response to therapy and graft survival","volume":"61","author":"Haas","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib40","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0041-1345(98)02003-X","article-title":"Morphologic criteria of chronic renal allograft rejection","volume":"31","author":"Mihatsch","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00002281-200309000-00001","article-title":"Update on vascular disease in systemic lupus erythematosus","volume":"15","author":"Kao","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.berh.2004.11.002","article-title":"How to diagnose and treat secondary forms of vasculitis","volume":"19","author":"Luqmani","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib43","series-title":"Clinical aspects of immunology","author":"Gell","year":"1963"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib44","series-title":"Immunology, immunopathology and immunity","first-page":"235","article-title":"Immunopathology","author":"Sell","year":"2003"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib45","first-page":"817","article-title":"Injections repetees de serum de cheval chez le lapin","volume":"55","author":"Arthus","year":"1903","journal-title":"V R Soc Biol"},{"issue":"3 Suppl","key":"10.1016\/j.clindermatol.2006.07.007_bib46","doi-asserted-by":"crossref","first-page":"7s","DOI":"10.1084\/jem.134.3.7","article-title":"Quantitation of acute and chronic serum sickness in the rabbit","volume":"134","author":"Wilson","year":"1971","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4049\/jimmunol.120.1.109","article-title":"Chemotactic response to human C3a and C5a anaphylatoxins: I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions","volume":"120","author":"Fernandez","year":"1978","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib48","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4049\/jimmunol.164.2.1065","article-title":"A codominant role of Fc gamma RI\/III and C5aR in the reverse Arthus reaction","volume":"164","author":"Baumann","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib49","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.186.5.749","article-title":"Impaired inflammatory responses in the reverse Arthus reaction through genetic deletion of the C5a receptor","volume":"186","author":"Hopken","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib50","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1126\/science.8066448","article-title":"Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade","volume":"265","author":"Sylvestre","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib51","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.167.2.1022","article-title":"Distinct tissue site-specific requirements of mast cells and complement components C3\/C5a receptor in IgG immune complex\u2013induced injury of skin and lung","volume":"167","author":"Baumann","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/1521-4141(200002)30:2<481::AID-IMMU481>3.0.CO;2-L","article-title":"Mouse FcgammaRII is a negative regulator of FcgammaRIII in IgG immune complex\u2013triggered inflammation but not in autoantibody-induced hemolysis","volume":"30","author":"Schiller","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib53","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.4049\/jimmunol.168.6.2970","article-title":"The cutaneous reverse Arthus reaction requires intercellular adhesion molecule 1 and l-selectin expression","volume":"168","author":"Kaburagi","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib54","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1172\/JCI115385","article-title":"Augmentation of reverse Arthus reaction by mast cells in mice","volume":"88","author":"Zhang","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib55","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0002-9440(10)64279-4","article-title":"Relative contributions of selectins and intercellular adhesion molecule-1 to tissue injury induced by immune complex deposition","volume":"162","author":"Yanaba","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1189\/jlb.1203650","article-title":"P-Selectin glycoprotein ligand-1 is required for the development of cutaneous vasculitis induced by immune complex deposition","volume":"76","author":"Yanaba","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib57","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/jcp.47.10.939","article-title":"Comparison of cell adhesion molecule expression in cutaneous leucocytoclastic and lymphocytic vasculitis","volume":"47","author":"Burrows","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archderm.133.4.443","article-title":"Adhesion molecule expression and endothelial cell activation in cutaneous leukocytoclastic vasculitis. An immunohistologic and clinical study in 42 patients","volume":"133","author":"Sais","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib59","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1034\/j.1600-0560.2000.027003130.x","article-title":"An immunohistopathologic study in cutaneous necrotizing vasculitis","volume":"27","author":"Bielsa","year":"2000","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N","article-title":"Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions","volume":"43","author":"Cid","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib61","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/1529-0131(199803)41:3<435::AID-ART9>3.0.CO;2-9","article-title":"Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa","volume":"41","author":"Coll-Vinent","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib62","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1468-3083.2004.00547.x","article-title":"The significance of immunohistochemistry in the skin pathergy reaction of patients with Behcet's syndrome","volume":"18","author":"Inaloz","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib63","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archderm.134.1.62","article-title":"Cellular and molecular dynamics in exercise-induced urticarial vasculitis lesions","volume":"134","author":"Kano","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib64","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/archderm.135.1.87","article-title":"Pathogenesis of exercise-induced urticarial vasculitis lesions: can the changes be extrapolated to all leukocytoclastic vasculitis lesions?","volume":"135","author":"Sais","year":"1999","journal-title":"Arch Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2006.07.007_bib65","doi-asserted-by":"crossref","first-page":"SII45","DOI":"10.3949\/ccjm.69.Suppl_2.SII45","article-title":"Endothelial cell biology, perivascular inflammation, and vasculitis","volume":"69","author":"Cid","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib66","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/rheumatology\/keh058","article-title":"Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis","volume":"43","author":"Hernandez-Rodriguez","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib67","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/archderm.134.4.447","article-title":"Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies","volume":"134","author":"Papi","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib68","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"issue":"6 Suppl 32","key":"10.1016\/j.clindermatol.2006.07.007_bib69","first-page":"S35","article-title":"New developments in the pathogenesis of ANCA-associated vasculitis","volume":"21","author":"Day","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2249.2005.02731.x","article-title":"Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis","volume":"140","author":"Marinaki","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11926-004-0067-3","article-title":"Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis","volume":"6","author":"Cid","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib72","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sable-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1440-0960.2005.00127.x","article-title":"Golfer's vasculitis","volume":"46","author":"Kelly","year":"2005","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib74","series-title":"Textbook of dermatology","first-page":"2155","article-title":"Cutaneous vasculitis","author":"Ryan","year":"1998"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib75","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-2133.1996.tb06325.x","article-title":"Leucocytoclastic vasculitis induced by prolonged exercise","volume":"134","author":"Prins","year":"1996","journal-title":"Br J Dermatol"},{"issue":"2 Suppl","key":"10.1016\/j.clindermatol.2006.07.007_bib76","doi-asserted-by":"crossref","first-page":"S602","DOI":"10.1067\/mai.2003.80","article-title":"15. Vasculitis","volume":"111","author":"Langford","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2006.07.007_bib77","doi-asserted-by":"crossref","first-page":"SII33","DOI":"10.3949\/ccjm.69.Suppl_2.SII33","article-title":"Implications for pathogenesis of patterns of injury in small- and medium-sized\u2013vessel vasculitis","volume":"69","author":"Jennette","year":"2002","journal-title":"Clevel Clin J Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib78","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1042\/bst0320502","article-title":"The importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis","volume":"32","author":"Harper","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib79","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMp048338","article-title":"The spectrum of Wegener's granulomatosis and disease relapse","volume":"352","author":"Bacon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib80","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/keh542","article-title":"Endothelial cells, fibroblasts and vasculitis","volume":"44","author":"Buckley","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib81","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0190-9622(03)00881-8","article-title":"Increased incidence of hypercoagulability in patients with leg ulcers caused by leukocytoclastic vasculitis","volume":"50","author":"Mekkes","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib82","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0738-081X(99)00081-4","article-title":"Coagulation and fibrinolysis in cutaneous vasculitis","volume":"17","author":"Claudy","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib83","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2133.2003.05459.x","article-title":"The coexistence of cutaneous vasculitis and thrombosis in childhood-onset systemic lupus erythematosus with antiphospholipid antibodies","volume":"149","author":"Tomizawa","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib84","first-page":"556","article-title":"The concomitant expression of vasculitis and coagulopathy: synergy for marked tissue ischemia","volume":"21","author":"Rocca","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib85","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/art.21704","article-title":"Thromboembolic events as a complication of antineutrophil cytoplasmic antibody\u2013associated vasculitis","volume":"55","author":"Weidner","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib86","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ard.2004.034231","article-title":"Prevalence of the antiphospholipid syndrome in primary systemic vasculitis","volume":"65","author":"Rees","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib87","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archderm.116.1.56","article-title":"Cutaneous periarteritis nodosa: immunofluorescence studies","volume":"116","author":"Diaz-Perez","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib88","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/096120339700600304","article-title":"Vasculitis in systemic lupus erythematosus","volume":"6","author":"Drenkard","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib89","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1067\/mjd.2003.212","article-title":"Cutaneous vasculitis","volume":"48","author":"Fiorentino","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib90","first-page":"56","article-title":"Clinical approach to cutaneous vasculitis","volume":"17","author":"Gonzalez-Gay","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib91","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/030097400750041334","article-title":"Is it possible to offer evidence-based treatment for systemic vasculitis?","volume":"29","author":"Luqmani","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib92","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11936-004-0042-3","article-title":"Primary cutaneous small vessel vasculitis","volume":"6","author":"Russell","year":"2004","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib93","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0738-081X(99)00074-7","article-title":"A clinical approach to the vasculitis patient in the dermatologic office","volume":"17","author":"Callen","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib94","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib95","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/rheumatology\/37.1.57","article-title":"Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI)","volume":"37","author":"Exley","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib96","first-page":"289","article-title":"Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients","volume":"20","author":"Guillevin","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib97","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib98","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00007611-198707000-00012","article-title":"Cutaneous leukocytoclastic vasculitis: clinical experience in 44 patients","volume":"80","author":"Callen","year":"1987","journal-title":"South Med J"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib99","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1651-2227.1997.tb08907.x","article-title":"Dapsone in cutaneous Henoch-Schonlein syndrome\u2014worth a trial","volume":"86","author":"Ramelli","year":"1997","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib100","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0190-9622(87)70100-5","article-title":"Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases","volume":"16","author":"Fredenberg","year":"1987","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.clindermatol.2006.07.007_bib101","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0190-9622(85)70158-2","article-title":"Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis","volume":"13","author":"Callen","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib102","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(94)92746-4","article-title":"Synergistic effects of pentoxifylline and dapsone in leucocytoclastic vasculitis","volume":"343","author":"Nurnberg","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib103","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2340\/00015555755456","article-title":"Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline","volume":"75","author":"Nurnberg","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib104","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archderm.131.12.1399","article-title":"Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial","volume":"131","author":"Sais","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1346-8138.2002.tb00263.x","article-title":"Dapsone in Behcet's disease: a double-blind, placebo-controlled, cross-over study","volume":"29","author":"Sharquie","year":"2002","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib106","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0002-9343(89)80607-2","article-title":"Low-antigen-content diet in the treatment of patients with mixed cryoglobulinemia","volume":"87","author":"Ferri","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib107","first-page":"131","article-title":"Elimination diet in the treatment of selected patients with hypersensitivity vasculitis","volume":"10","author":"Lunardi","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib108","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1001\/jama.247.14.1994","article-title":"Chronic, recurrent small-vessel cutaneous vasculitis. Clinical experience in 13 patients","volume":"247","author":"Cupps","year":"1982","journal-title":"JAMA"},{"issue":"6 Suppl 36","key":"10.1016\/j.clindermatol.2006.07.007_bib109","first-page":"S31","article-title":"Localized nodular vasculitis: a new variant of localized cutaneous polyarteritis nodosa?","volume":"22","author":"Quintana","year":"2004","journal-title":"Clin Exp Rheumatol"},{"issue":"6 Pt 1","key":"10.1016\/j.clindermatol.2006.07.007_bib110","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0190-9622(91)70156-V","article-title":"Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behcet's disease","volume":"24","author":"Jorizzo","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib111","first-page":"763","article-title":"Methotrexate in the treatment of vasculitic cutaneous ulceration in rheumatoid arthritis","volume":"82","author":"Williams","year":"1989","journal-title":"J R Soc Med"},{"issue":"2 Pt 2","key":"10.1016\/j.clindermatol.2006.07.007_bib112","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0190-9622(87)70212-6","article-title":"Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis","volume":"17","author":"Upchurch","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib113","first-page":"1674","article-title":"A 2 year, open ended trial of methotrexate in systemic lupus erythematosus","volume":"21","author":"Wilson","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib114","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/ard.56.6.382","article-title":"Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease)","volume":"56","author":"Gansauge","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1345\/aph.1A124","article-title":"Cutaneous and systemic manifestations of drug-induced vasculitis","volume":"36","author":"ten Holder","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib116","first-page":"253","article-title":"The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate","volume":"23","author":"Kaye","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib117","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archderm.127.4.515","article-title":"Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis","volume":"127","author":"Callen","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib118","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0002-9343(96)00405-6","article-title":"Clinical features and outcome of 95 patients with hypersensitivity vasculitis","volume":"102","author":"Martinez-Taboada","year":"1997","journal-title":"Am J Med"},{"issue":"5 Pt 1","key":"10.1016\/j.clindermatol.2006.07.007_bib119","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0091-6749(84)90518-9","article-title":"The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxychloroquine","volume":"73","author":"Lopez","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1191\/096120398678919778","article-title":"A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group","volume":"7","author":"Tsakonas","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib121","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1468-3083.1996.tb00156.x","article-title":"Cyclosporin A in the treatment of cutaneous vasculitis. Clinical and cellular effects","volume":"6","author":"Tosca","year":"1996","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib122","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/09546639409084539","article-title":"Cyclosporin\u2014a therapy for allergic cutaneous vasculitis","volume":"5","author":"Stratigos","year":"1994","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib123","doi-asserted-by":"crossref","first-page":"480","DOI":"10.5414\/CNP64480","article-title":"What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides","volume":"64","author":"de Groot","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib124","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00296-002-0208-9","article-title":"Severe Henoch-Schonlein nephritis: resolution with azathioprine and steroids","volume":"22","author":"Singh","year":"2002","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib125","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1365-2133.2000.03913.x","article-title":"Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis","volume":"143","author":"Worm","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib126","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1526-0968.2001.00300.x","article-title":"Plasmapheresis in antineutrophil cytoplasmic antibody\u2013associated systemic vasculitis","volume":"5","author":"Gaskin","year":"2001","journal-title":"Ther Apher"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib127","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2133.1990.tb08291.x","article-title":"Plasma exchange in refractory cutaneous vasculitis","volume":"122","author":"Turner","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib128","first-page":"767","article-title":"Intravenous immunoglobulin in childhood cutaneous polyarteritis nodosa","volume":"16","author":"Gedalia","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2133.2000.03681.x","article-title":"Successful treatment of chronic leucocytoclastic vasculitis and persistent ulceration with intravenous immunoglobulin","volume":"143","author":"Ong","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1385\/CRIAI:29:3:237","article-title":"Intravenous immunoglobulin therapy in vasculitis: speculation or evidence?","volume":"29","author":"Aries","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib131","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.ajkd.2005.04.018","article-title":"Systemic vasculitis: still a challenging disease","volume":"46","author":"Buhaescu","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 4","key":"10.1016\/j.clindermatol.2006.07.007_bib132","doi-asserted-by":"crossref","first-page":"iv31","DOI":"10.1136\/ard.2005.042416","article-title":"Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis","volume":"64","author":"Mukhtyar","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib133","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.autrev.2004.06.001","article-title":"TNF-alpha inhibitors in systemic vasculitides and connective tissue diseases","volume":"4","author":"Lamprecht","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib134","first-page":"72","article-title":"B-Cell depletion for rheumatic diseases: where are we?","volume":"7","author":"Cohen","year":"2005","journal-title":"Med Gen Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clim.2005.08.006","article-title":"The therapeutic potential of anti-CD20 \u201cwhat do B-cells do?\u201d","volume":"117","author":"Eisenberg","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib136","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/ard.2005.043638","article-title":"Infliximab leads to a rapid but transient improvement in endothelial function in patients with primary systemic vasculitis","volume":"65","author":"Raza","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib137","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.0000124720.18538.DD","article-title":"Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation","volume":"109","author":"Booth","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib138","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/41.11.1303","article-title":"Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis","volume":"41","author":"Lamprecht","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib139","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti\u2013TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib140","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","article-title":"Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody\u2013associated systemic vasculitis","volume":"15","author":"Booth","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib141","first-page":"1607","article-title":"Rheumatoid vasculitis treated with infliximab","volume":"32","author":"van der Bijl","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib142","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaad.2005.02.009","article-title":"Response of deep cutaneous vasculitis to infliximab","volume":"53","author":"Uthman","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib143","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11936-005-0015-1","article-title":"Behcet's disease: current therapeutic perspectives","volume":"7","author":"Leiba","year":"2005","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib144","first-page":"759","article-title":"Successful treatment of rheumatoid vasculitis\u2013associated foot-drop with infliximab","volume":"32","author":"Armstrong","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib145","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaad.2004.01.003","article-title":"Therapy for severe necrotizing vasculitis with infliximab","volume":"51","author":"Mang","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib146","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/rheumatology\/keh080","article-title":"Infliximab in the treatment of refractory vasculitis secondary to hepatitis C\u2013associated mixed cryoglobulinaemia","volume":"43","author":"Chandesris","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib147","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.62.6.587","article-title":"Successful treatment of severe rheumatoid vasculitis by infliximab","volume":"62","author":"Unger","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib148","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2474-4-19","article-title":"Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report","volume":"4","author":"Gulli","year":"2003","journal-title":"BMC Musculoskelet Disord"},{"issue":"6 Suppl 32","key":"10.1016\/j.clindermatol.2006.07.007_bib149","first-page":"S138","article-title":"Successful response to infliximab in a patient with undifferentiated spondyloarthropathy coexisting with polyarteritis nodosa\u2013like cutaneous vasculitis","volume":"21","author":"Garcia-Porrua","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib150","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","author":"Stone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib151","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.rhu.0000173225.41933.83","article-title":"Successful treatment of childhood onset refractory polyarteritis nodosa with tumor necrosis factor alpha blockade","volume":"11","author":"Feinstein","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib152","first-page":"729","article-title":"Successful treatment of resistant Behcet's disease with etanercept","volume":"23","author":"Atzeni","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib153","first-page":"98","article-title":"Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study","volume":"32","author":"Melikoglu","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib154","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.62.4.373","article-title":"Successful treatment of resistant giant cell arteritis with etanercept","volume":"62","author":"Tan","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib155","first-page":"733","article-title":"Treatment of recurrent oral aphthous ulcers with etanercept","volume":"20","author":"Scheinberg","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib156","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib157","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib158","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ndt\/gfh564","article-title":"Remission of refractory hepatitis C\u2013negative cryoglobulinaemic vasculitis after rituximab and infliximab","volume":"20","author":"Koukoulaki","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib159","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2796.2005.01494.x","article-title":"Nine patients with anti-neutrophil cytoplasmic antibody\u2013positive vasculitis successfully treated with rituximab","volume":"257","author":"Eriksson","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib160","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial","volume":"173","author":"Keogh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib161","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody\u2013associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib162","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.bor.0000198002.42826.c2","article-title":"Cryoglobulinemic vasculitis","volume":"18","author":"Ferri","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib163","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"5 Suppl","key":"10.1016\/j.clindermatol.2006.07.007_bib164","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1016\/S0190-9622(03)00744-8","article-title":"Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: rapid response to rituximab","volume":"49","author":"Saigal","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib165","first-page":"1885","article-title":"Tumor necrosis factor\u2013alpha blockade and the risk of vasculitis","volume":"31","author":"Guillevin","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib166","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3083.2005.01570.x","article-title":"Immunology of cutaneous vasculitis associated with both etanercept and infliximab","volume":"61","author":"Srivastava","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib167","first-page":"2287","article-title":"Anti\u2013tumor necrosis factor\u2013alpha therapy\u2013induced vasculitis: case series","volume":"30","author":"Jarrett","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib168","first-page":"1955","article-title":"Leukocytoclastic vasculitis associated with tumor necrosis factor\u2013alpha blocking agents","volume":"31","author":"Mohan","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib169","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archderm.142.2.246","article-title":"Rituximab-induced leukocytoclastic vasculitis: a case report","volume":"142","author":"Kandula","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.007_bib170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000051713","article-title":"Rituximab-induced vasculitis","volume":"203","author":"Dereure","year":"2001","journal-title":"Dermatology"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X0600099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X0600099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T11:22:26Z","timestamp":1707218546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X0600099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":170,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0738081X0600099X"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2006.07.007","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}